The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial Cells
Open Access
- 1 August 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (33) , 25781-25790
- https://doi.org/10.1074/jbc.m001235200
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Advanced glycation end products increase retinal vascular endothelial growth factor expression.Journal of Clinical Investigation, 1998
- TGFβ Signaling: Receptors, Transducers, and Mad ProteinsCell, 1996
- Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin‐producing ability of endothelial cells through interactions with their receptorsFEBS Letters, 1996
- Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and PericytesJournal of Biological Chemistry, 1995
- Tumor Necrosis Factor α-induced Phosphorylation of Insulin Receptor Substrate-1 (IRS-1)Journal of Biological Chemistry, 1995
- Receptor-Mediated Toxicity to Pericytes of Advanced Glycosylation End Products: A Possible Mechanism of Pericyte Loss in Diabetic MicroangiopathyBiochemical and Biophysical Research Communications, 1995
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Effect of Pregnancy on Progression of Diabetic RetinopathyDiabetes Care, 1990
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988